When should copper levels be tested in patients with altered mental status?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Test Copper Levels in Patients with Altered Mental Status

Copper levels should be tested in patients with altered mental status who have risk factors for copper abnormalities, particularly those with unexplained neurological symptoms, history of bariatric surgery, or signs of liver disease.

Indications for Copper Testing in Altered Mental Status

Primary Indications

  • Neurological symptoms accompanying altered mental status:

    • Unexplained sensory and/or motor symptoms 1
    • Gait abnormalities 1
    • Ataxia 2
    • Movement disorders in young patients 1
    • Psychiatric symptoms, especially depression 1
  • Risk factors for copper deficiency:

    • History of bariatric surgery 1, 2
    • Malabsorption syndromes 3
    • Prolonged parenteral nutrition 1
    • Unexplained anemia or fatigue 1
  • Risk factors for copper excess (Wilson's disease):

    • Unexplained liver disease, especially in young patients 1
    • Family history of Wilson's disease 1
    • Acute hepatitis with hemolytic anemia 1
    • Behavioral changes in adolescents 1

Secondary Indications

  • Unexplained pancytopenia 2
  • Abnormal liver function tests of unclear etiology 1
  • Psychiatric symptoms that appear disproportionate to clinical situation 1
  • Patients requiring unusually high insulin doses (for chromium, but copper should be tested concurrently) 1

Diagnostic Approach

For Suspected Wilson's Disease

  1. Initial testing:

    • Serum ceruloplasmin (low levels <0.1 g/L strongly suggest Wilson's disease) 1
    • Serum copper (may be low, normal, or high depending on disease stage) 1
    • 24-hour urinary copper excretion (>100 μg/24 hours suggests Wilson's disease) 1
  2. Additional testing:

    • Slit-lamp examination for Kayser-Fleischer rings 1
    • Calculation of non-ceruloplasmin bound copper (>25 μg/dL suggests Wilson's disease) 1
    • Consider liver biopsy for hepatic copper content (>4 μmol/g dry weight is diagnostic) 1

For Suspected Copper Deficiency

  1. Initial testing:

    • Serum copper levels 1
    • Serum ceruloplasmin 1
  2. Additional testing:

    • Complete blood count (look for anemia, neutropenia) 4
    • Nerve conduction studies if neuropathy is suspected 2

Interpretation Challenges

  • Ceruloplasmin levels may be falsely normal in Wilson's disease during inflammation 1
  • Ceruloplasmin may be low in conditions other than Wilson's disease (malabsorption, aceruloplasminemia, heterozygous carriers) 1, 4
  • Serum copper may be elevated in acute liver failure of any etiology, not just Wilson's disease 1
  • Non-ceruloplasmin bound copper calculation depends on accurate measurement of both serum copper and ceruloplasmin 1

Clinical Pearls

  • Copper deficiency can present with neurological symptoms similar to vitamin B12 deficiency (subacute combined degeneration) 2
  • When testing for copper deficiency, always check zinc levels as well, as high zinc supplementation can cause copper deficiency 1
  • Maintain a ratio of 8-15 mg zinc to 1 mg copper when supplementing both minerals 1, 5
  • Free copper levels (non-ceruloplasmin bound) may correlate with cognitive function even in otherwise normal individuals 6
  • Permanent neurological damage can occur if copper deficiency is not diagnosed and treated promptly 2

Remember that copper abnormalities can present with subtle neuropsychiatric symptoms before more obvious physical manifestations appear, making them an important consideration in the workup of altered mental status with unclear etiology.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Abnormal copper metabolism in adult].

La Revue de medecine interne, 2010

Guideline

Treatment of Elevated Copper Levels

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Is cognitive function linked to serum free copper levels? A cohort study in a normal population.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.